HomeHealthInfectious Disease Scientist to Lead N.I.A.I.D. Amid Turmoil

Infectious Disease Scientist to Lead N.I.A.I.D. Amid Turmoil

Dr. John H. Powers III, an infectious disease researcher, was appointed on Monday to lead the National Institutes of Health division on infectious diseases, giving him control of a politically contentious institute with a budget of over $6.5 billion and responsibility for research into such pressing threats as measles and Ebola.

His designation as director of the National Institute of Allergy and Infectious Diseases, a position held for nearly four decades by Dr. Anthony S. Fauci, caps a rapid rise for Dr. Powers, who until recently was an N.I.H. contractor and clinical trials design specialist.

Since the start of the second Trump administration, Dr. Powers gained influence among senior health officials as he was tapped to study vaccine injuries, a priority of Health Secretary Robert F. Kennedy Jr.

Early last year, Dr. Powers worked with Dr. Matthew Memoli, the No. 2 official at the N.I.H. and a critic of Covid vaccine mandates, to obtain sets of data related to vaccines and autism from the Centers for Disease Control and Prevention, according to emails reviewed by The New York Times.

The emails said that Dr. Powers and possibly other N.I.H. contractors would be analyzing the C.D.C. data, and that autism scientists at the N.I.H. had been unaware of N.I.H. leaders’ requests for the data. (Past large studies have found no link between vaccines and autism.)

After he was put in charge of the infectious diseases institute on a temporary basis around the middle of this year, Dr. Powers helped develop a major research study on health problems following vaccination or infection.

He appeared beside Mr. Kennedy at an N.I.H. event announcing the initiative, counting down before the health secretary cut the ribbon for cameras.

At a briefing on Monday, Dr. Powers said that he had never studied the link between vaccines and autism and that the question of whether vaccines caused autism was a “policy question” that was beyond his remit as director of the infectious diseases institute.

The N.I.H. said that Dr. Powers did not ultimately perform any work on the C.D.C. vaccine data.

“The real question here now is, ‘Can we have the evidence to actually show where and in what populations a vaccine is beneficial for people?’” Dr. Powers said. “And benefits are actually what justify any potential harms.”

An expert on the design of clinical trials, Dr. Powers made his name developing a widely used measure of the severity of flu symptoms.

Dr. Powers has also worked at Leidos Biomedical Research, a company that supports government research efforts; held an academic appointment at the George Washington University School of Medicine; and treated patients as an infectious diseases specialist.

His sensitivity to the rare but serious side effects of vaccines has endeared him to supporters. Some colleagues said that Dr. Powers has sought to ensure that N.I.H. studies of vaccine harms hewed to scientific goals, and not a political agenda.

Brianne Dressen, who was diagnosed with post-vaccine neuropathy after participating in a clinical trial in 2020 of AstraZeneca’s Covid vaccine, which was never widely administered in the United States, said she met Dr. Powers this summer as they worked together on the N.I.H.’s vaccine injury study.

“He understands that these aren’t just study participants,” Ms. Dressen, a patient adviser on the N.I.H. study, said in an interview. “He understands these are real patients, and especially dealing with people with severe chronic conditions, these are very vulnerable patients.”

Diana Zuckerman, a scientist and the president of the nonprofit National Center for Health Research, who has worked with Dr. Powers, described him as “a moderate on these issues.”

“He’s absolutely committed to ensuring that as many people can safely get vaccines as possible,” she said. “Like many of us,” she added, Dr. Powers “recognized that some people are harmed by vaccines, and the numbers are proportionally small, but the harm can be great.”

Since President Trump returned to office last year, the country’s infectious diseases research apparatus has been thrown into chaos, generating alarm among Democrats in Congress amid outbreaks of hantavirus and Ebola.

Dr. John H. Powers IIICredit…National Institute of Allergy and Infectious Diseases

Dr. Fauci’s successor, Dr. Jeanne Marrazzo, a scientist renowned for research on sexually transmitted infections, was fired by Mr. Kennedy last year after she filed a whistle-blower complaint against the Trump administration. (She has since sued the administration; a federal judge this month denied a government bid to have the lawsuit dismissed.)

Then Dr. Jeffery Taubenberger, who had led a major effort to sequence the 1918 Spanish flu virus and who stepped in as acting director of the infectious diseases institute last year, was pushed aside, creating weeks of uncertainty this year about who was running the institute.

Federal investigators have also demanded phone, email, grant and payment records related to a number of infectious disease scientists, including Dr. Fauci, as part of a sprawling set of inquiries related to the origins of the Covid pandemic.

And several large research networks that test vaccines and treatments for H.I.V., tuberculosis and emerging infectious diseases remain in limbo after delays from the Trump administration in starting the process to renew their funding.

During Dr. Powers’s tenure as acting director of the infectious diseases institute, the second-largest arm of the N.I.H., officials said that he has defended the agency’s portfolio. But the Trump administration has exercised an unusual level of control over medical research funding decisions.

And some scientists worried that Dr. Powers did not have the same breadth of infectious disease research experience as his predecessors, putting him at a disadvantage as he fills the leadership vacuum at the country’s premier infectious disease institute.

In January, Dr. Powers appeared on a panel about the future of the infectious diseases institute organized by the MAHA Institute, which is led by Tony Lyons, a longtime friend and business associate of Mr. Kennedy’s.

Apoorva Mandavilli and Carolyn Y. Johnson contributed reporting.

Source link

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

Recent Comments